Unknown PHASE4 INTERVENTIONAL 2-arm NCT00449098

Ologen (OculusGen)-Glaucoma MMC Control Trial in India

Comparative Study of the Safety and Effectiveness Between Ologen (OculusGen) Collagen Matrix Implant and Mitomycin-C in Glaucoma Filtering Surgery

Sponsor: Pro Top & Mediking Company Limited

Conditions Glaucoma

Interventions OculusGen Biodegradable Collagen Matrix Implant Trabeculectomy with MMC

Updated 5 times since 2017 Last updated: Oct 6, 2011 Started: Jan 31, 2007 Primary completion: Oct 31, 2011 Completion: Oct 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Glaucoma, this trial is ongoing. The trial is conducted by Pro Top & Mediking Company Limited and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pro Top & Mediking Company Limited

Data source: Pro Top & Mediking Company Limited

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hyderabad, India